STRONG BUY
Can't believe how far down it's at now, at 30% discount to its book value. This has big, big upside. Has a $21 book value, which this could reach without breathing hard. Sometimes stocks sell-off irrationally.
DON'T BUY
He wouldn't touch it. It's very expensive on a P/B basis and FMV (fair market value). Sometimes, the market will carry a stock that doesn't deserve it. Consider yourself lucky for owning this, but he would then get out of it. The chart (showing strength in the past few years) is looking in the rear-view mirror. He doesn't see upside.
DON'T BUY
He understands this will get folded into the Enbridge parent. He's always liked this stock, but not anymore. So, look at Enbridge, which has some value, but is also not very exciting.
DON'T BUY
Considering current issues with Saudi Arabia and legal headwinds The analysts have knocked down their earnings forecasts. If this reached its FMV it would hit $64, a huge rebound. Good technical support at $47-49. How serious is this Saudi Arabia issue, and would a Canadian company get punished operating there? He doesn't buy companies with political problems. That said, SNC is really cheap now and you can roll the dice, if you wish.
TOP PICK
Pays a good 5.7% yield. It could be quite defensive in weak markets, and has done well in this current bear market, which is a good sign. It's at 2.5x book value. This could give you a nice capital plus the yield. (Analysts’ price target is $59.03)
TOP PICK
It ran into a short-seller and a lawsuit, but the courts have since sided with MFC. The short-seller was taking advantage in MFC and they appear to have been beaten back. MFC itself has been beaten down and is now swinging back, so buy this now. 4.6% dividend. (Analysts’ price target is $29.34)
TOP PICK
The balance sheet of America is really grim, and Trump isn't helping it. The country can't afford another tax cut. (Europe and Japan are in the same mess.) So, it's a good time to accumulate gold stocks. Goldcorp got hammered when they reported earnings recently. They should have released their bad news weeks ago to prevent a sharp sell-off. They had some overburden issues and their earnings have bounced back. It's now cheap. (Analysts’ price target is $18.08)